Tyrosine administration decreases glutathione and stimulates lipid and protein oxidation in rat cerebral cortex

[1]  M. Wajner,et al.  Tyrosine promotes oxidative stress in cerebral cortex of young rats , 2008, International Journal of Developmental Neuroscience.

[2]  J. Sarles,et al.  NTBC treatment in tyrosinaemia type I: Long-term outcome in French patients , 2008, Journal of Inherited Metabolic Disease.

[3]  P. Held.  Disorders of tyrosine catabolism. , 2006, Molecular genetics and metabolism.

[4]  Barry Halliwell,et al.  Oxidative stress and neurodegeneration: where are we now? , 2006, Journal of neurochemistry.

[5]  M. Barzegari,et al.  Oculocutaneous tyrosinaemia or tyrosinaemia type 2: a case report , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[6]  P. Mullins,et al.  Transient neonatal tyrosinaemia , 1989, Journal of Inherited Metabolic Disease.

[7]  R. Wurtman,et al.  Regional tyrosine levels in rat brain after tyrosine administration , 2005, Journal of Neural Transmission.

[8]  M. Wajner,et al.  The role of oxidative damage in the neuropathology of organic acidurias: Insights from animal studies , 2004, Journal of Inherited Metabolic Disease.

[9]  Dean P. Jones,et al.  Extracellular thiols and thiol/disulfide redox in metabolism. , 2004, Annual review of nutrition.

[10]  E. Holme,et al.  Outcome of tyrosinaemia type III , 2001, Journal of Inherited Metabolic Disease.

[11]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[12]  R. Bongiovanni,et al.  Pharmacokinetics of systemically administered tyrosine: a comparison of serum, brain tissue and in vivo microdialysate levels in the rat , 2003, Journal of neurochemistry.

[13]  E. Stadtman,et al.  Free radical-mediated oxidation of free amino acids and amino acid residues in proteins , 2003, Amino Acids.

[14]  M. Macsai,et al.  Tyrosinemia type II: nine cases of ocular signs and symptoms. , 2001, American journal of ophthalmology.

[15]  R. Tanguay,et al.  Tyrosinemia: A Review , 2001, Pediatric and Developmental Pathology.

[16]  M. Anderson,et al.  Glutathione: an overview of biosynthesis and modulation. , 1998, Chemico-biological interactions.

[17]  R. Browne,et al.  Reduced glutathione and glutathione disulfide. , 1998, Methods in molecular biology.

[18]  M. Rice,et al.  Differential compartmentalization of brain ascorbate and glutathione between neurons and glia , 1997, Neuroscience.

[19]  M. Rudra,et al.  Inhibition of Tyrosine Aminotransferase by β‐N‐Oxalyl‐l‐α,β‐Diaminopropionic Acid, the Lathyrus sativus Neurotoxin , 1997 .

[20]  S. Rao,et al.  Inhibition of tyrosine aminotransferase by beta-N-oxalyl-L-alpha,beta-diaminopropionic acid, the Lathyrus sativus neurotoxin. , 1997, Journal of neurochemistry.

[21]  E. Lock,et al.  Tissue distribution of 2-(2-nitro-4-trifluoromethylbenzoyl)cyclohexane-1-3-dione (NTBC): effect on enzymes involved in tyrosine catabolism and relevance to ocular toxicity in the rat. , 1996, Toxicology and applied pharmacology.

[22]  P. Kaplan,et al.  Painful keratoderma and photophobia: hallmarks of tyrosinemia type II. , 1995, The Journal of pediatrics.

[23]  R. Kletzien,et al.  Glucose‐6‐phosphate dehydrogenase: a “housekeeping” enzyme subject to tissue‐specific regulation by hormones, nutrients, and oxidant stress , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  L. Packer,et al.  Oxidative damage to proteins: spectrophotometric method for carbonyl assay. , 1994, Methods in enzymology.

[25]  L. Packer,et al.  Free Radicals and Antioxidants in Muscular and Neurological Diseases and Disorders , 1993 .

[26]  G. Poli,et al.  Free Radicals: from Basic Science to Medicine , 1993 .

[27]  H. Esterbauer,et al.  Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. , 1990, Methods in enzymology.

[28]  D. W. Thomas.  Handbook of Methods for Oxygen Radical Research , 1988, Journal of Pediatric Gastroenterology and Nutrition.

[29]  B. Halliwell,et al.  Oxygen radicals and the nervous system , 1985, Trends in Neurosciences.

[30]  J. Milei,et al.  Comparison of Lipid Peroxidation and Myocardial Damage Induced by Adriamycin and 4′-Epiadriamycin in Mice , 1985, Tumori.

[31]  S. Leong,et al.  Regional enzyme development in rat brain. Enzymes associated with glucose utilization. , 1984, The Biochemical journal.

[32]  H. Aebi,et al.  Catalase in vitro. , 1984, Methods in enzymology.

[33]  A. Wendel.  [44] Glutathione peroxidase , 1981 .

[34]  K. Yagi,et al.  Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. , 1979, Analytical biochemistry.

[35]  M. Odiévre,et al.  Tyrosine aminotransferase isoenzyme deficiency. , 1979, The Journal of pediatrics.

[36]  S. Omaye,et al.  Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. , 1979, Methods in enzymology.

[37]  E. Hitchcock,et al.  Intellectual deficits after transient tyrosinemia in the term neonate. , 1976, Pediatrics.

[38]  G. Löhr,et al.  Glucose-6-phosphate Dehydrogenase , 1974 .

[39]  L. Goldsmith,et al.  Tyrosinemia with plantar and palmar keratosis and keratitis. , 1973, The Journal of pediatrics.

[40]  I. Light,et al.  Clinical significance of tyrosinemia of prematurity. , 1973, American journal of diseases of children.

[41]  W. Cleland,et al.  A specific and sensitive assay for disulfides. , 1968, The Journal of biological chemistry.

[42]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.